Cancer in the News #16: New tests, treatments, and risks for cancers. Fraud and studies to participate in.

Kaiulani Facciani

·

Follow

4 min read

·

Oct 19, 2021

--

Share

6/6/21: 16th issue: Contents

• Lynparza reduced risk of cancer recurrence by 42% in patients with germline BRCA-mutated high-risk early breast cancer
• Blood Test for 50 Cancers Coming to US Clinics Soon
• One of the Biggest Healthcare Frauds Ever Is Still Ongoing
• Three studies you may wish to participate in to support research:
• - Predicting Brain Health After Chemotherapy
• - Genomic Analysis of Long-Term Survivors with Metastatic Cancer
• - Risk Factor Analysis of Hereditary Breast and Ovarian Cancer
• Freezing Breast Cancer to Death Avoids Surgery
• AHA Statement Flags CardioVascular Risk of Hormonal Cancer Therapies
• Biologic Drug Nearly Doubles Overall Survival in Metastatic Triple-Negative Breast Cancer

• Lynparza reduced risk of cancer recurrence by 42% in patients with germline BRCA-mutated high-risk early breast cancers